Episodes / Mushrooms for the Mind & Immune System | Paul Stamets /

Full transcript

Mushrooms for the Mind & Immune System | Paul Stamets · 2:28:55 · 2388 segments · transcribed with distil-large-v3 on Nov 17, 2026. Timestamps open the source at that second.

  1. It was extraordinary.

  2. I refused to be an apologist for my interest in psilocybin.

  3. And now it's a revolution, sweeping the planet.

  4. There's a revolution from the underground.

  5. 2.5% of Americans admitted they use psilocybin.

  6. last year. Microdosing or macrodosing? Both. That's over 8 million on my calculation

  7. Americans. Do you think this is because of the studies on repeated use of psilocybin as beneficial

  8. for major depression? Yes. Yes. The clinical trials. For people who are depressed, PTSD,

  9. all sorts of other. And then increasingly, there is evidence that psilocybin increases

  10. neuroplasticity and creates new neural networks.

  11. And that's the area we have focused a lot of attention on.

  12. I'm with a research group, and we're very excited about what we're seeing.

  13. Other scientists are now also showing the same thing.

  14. The observational studies, and this is easily discoverable,

  15. anybody wants to search the web for this,

  16. specifically significant association of an deduction of crime

  17. with a person who's done one dose of celltobin,

  18. partner-to-partner violence,

  19. two heroic doses of cellocybin, 90% of people addicted to tobacco compared to the nicotine patch, one year later, we're not smoking.

  20. So we define heroic dose?

  21. Let me define it in several ways.

  22. For those of you who know what psilocybe capensis, the golden tops, that's the most commonly cultivated mushroom, psilocybin mushroom in the world, super easy to cultivate.

  23. That typically is over two and a half grams.

  24. Really, the hero's journey is around four to five grams.

  25. This is where you have set in setting,

  26. and it's so important you have therapy afterwards.

  27. It's so important that people don't do it.

  28. Would you say before, during, and afterward?

  29. Preparatory is really important,

  30. so you don't have to understand

  31. what you're going to experience.

  32. There's a great nonprofit in Canada called Roots to Thrive.

  33. Dr. Pamela Criscoe is one of the co-founders of it.

  34. They really have a lot of experience with end of life

  35. permitted by the Canadian government,

  36. you know, on a case-by-case basis.

  37. Yeah, we should probably, before we continue,

  38. forgive me for interoperative. We should touch on legality and we should touch on categories of

  39. humans for which there's could be elevated risk. So as far as I know, as far as I know,

  40. psilocybin has been decriminalized in the United States in a few places, but is still,

  41. I have to pronounce this very clearly illegal to possess or sell. That's my understanding.

  42. Absolutely. Very important. And you cross, you know, state lines. You're involved in interstate

  43. transportation of a Schedule I drug.

  44. Possession of it is federally illegal.

  45. Transportation across state lines is very federally illegal.

  46. So Oregon and Colorado have decriminalized.

  47. I've spoken in front of two city councils in Washington State

  48. and unanimity of the city councils to decriminalize the possession of

  49. cell asylum to the lowest priority of law enforcement.

  50. This is one of the few times I'm going to say, lawyers,

  51. what a great idea you came up with.

  52. They made less of a violation than a parking ticket.

  53. So they decriminalize it.

  54. Didn't legalize it.

  55. So Olympia, Seattle, Mount Vernon, Port Townsend.

  56. All the places with a lot of trees, Oregon, Colorado.

  57. What about categories of risk?

  58. So my understanding of the literature is that people who have a genetic or, let's just say, familial or other predisposition to psychosis or bipolar disorder need to be very, very careful.

  59. This is very, very serious.

  60. They need to be pre-screened.

  61. They need to, we need to have adults in the room on this.

  62. This is not a party drug.

  63. This is a serious medicine.

  64. 70% of people typically have a positive experience.

  65. The Compass Sulocybin studies are showing about 40%, 45% resolution of treatment-resistant

  66. depression or major depressive disorder.

  67. I don't remember which.

  68. But it's clearly a very powerful medicine.

  69. Doesn't it work for everyone?

  70. Very interestingly, Johns Hopkins, Roland Griffiths, who unfortunately passed away,

  71. he had already led the charge on this.

  72. They had a retro-respective study 14 months after heroic doses of psilocybin.

  73. They interviewed the individuals, and as I remember, about 70% of the individuals described it as an extremely positive experience in the top five positive experiences of our life.

  74. 30% of the people described it as a difficult experience.

  75. But the 70% of the people, 14 months later, they determined the act of re-remembering this experience was psychologically beneficial.

  76. They relive the experience.

  77. Well, that's reliving a neural pathway and a memory.

  78. The 30% of the people had a difficult experience,

  79. there was no adverse effects post the experience, 14 months later.

  80. They just said, not for me.

  81. I'm not going to do that again.

  82. That was too difficult.

  83. So people have schizophrenia, psychosis, absolutely.

  84. This is truly a mind-bender.

  85. But that so many people can benefit from this.

  86. And people need to realize this is the end.

  87. anti-addictive drug. So many people, when they take a high dose of psilocybin, they look at the

  88. mushrooms the next day and they say, no way, I'm not touching those. Many people use it one time in

  89. their life, one time. Think of that. This is why for opioid use disorder, for tobacco, for alcoholism,

  90. for all these addictive, for obsessive compulsive disorder, which is what we're involved in right now,

  91. this seems to reprogram

  92. not only the neuroescape

  93. but we know there's dandritic tips

  94. of being formed from the tips of the axons

  95. and when these dendritic

  96. spines grow out

  97. and the adjacent axons

  98. and they touch each other, you have synaptogenesis

  99. and then you have neuroplasticity of a new neural pathway

  100. in order to be able to think.

  101. You have another way of breaking your addictive behavior

  102. because you're not stuck in a rot.

  103. And that's what so exciting is the neuroplasticity benefits of psilocybin.

  104. Everything we're doing right now, Andrew, is related to the health of our nervous system,

  105. our seeing, or listening, or allocuting, me trying to formulate thoughts.

  106. It's all based on the health of our nervous system.

  107. I think psilocybin will go down as a paradigm shifting drug rediscovered

  108. that could have the most dramatic impact for the health of individuals

  109. and society of any medicine discovered in history.

  110. That's what I believe.

  111. That's a big statement.

  112. I spent some time with the clinical trials on psilocybin for major depression, a little bit

  113. on the data for OCD.

  114. And I should just point out, we're not talking about OCD of that this person is really

  115. nitpicky, quote-unquote, anal retent.

  116. We're talking about people whose compulsive behavior is actually strengthened the obsessions,

  117. and that's a vicious loop.

  118. It's very, very detrimental to everyday living.

  119. So if these things can provide relief, and the clinical trials are very encouraging,

  120. I'm on board.

  121. I do have a question.

  122. I just would like your thoughts.

  123. As you point out mechanistically, we know that psilocybin can create new neuronal connections

  124. in the brain, maybe unmask existing connections as well, from what I understand.

  125. I've been intrigued by the sort of paradox where plasticity is great, but the directing the plasticity

  126. toward a particular endpoint, the resolution of the depression, of the obsessions, of the excessive

  127. ruminations.

  128. I mean, that's sort of the goal, right?

  129. It's not plasticity.

  130. It's directed plasticity.

  131. And there I feel like that the qualified therapy plays a critical role, right?

  132. It's not clear that people can just kind of freestyle this.

  133. And so I think that for me, the big question in the psychedelic therapy's realm is the experience of the psychedelic, like the thoughts, the, they're unusual, you know, compared to everyday life.

  134. Are the thoughts, are the, is the therapy, is what we say and what we hear, what we think and what we feel during those psychedelic sessions.

  135. is that critical to the clinical outcome?

  136. Because ultimately, there's also a lot of neurochemistry happening that facilitates plasticity.

  137. So maybe we don't care about separating those two.

  138. But I think if people are going to use these powerful compounds to try and be healthier,

  139. I think it's going to be really important to figure out what should they be asked during these sessions.

  140. I don't think any of that is standardized.

  141. Like we can say more about dosage and strain than we can about what a good psychedelic therapy should look like.

  142. Absolutely.

  143. It's so important.

  144. Let me just bring it back from my perspective.

  145. My father, who was a pro-Nixon anti-drug guy in his 70s,

  146. it said, Paul, how I'm going to do Sulzheimer's with you?

  147. How old was he when he said that?

  148. What, 74?

  149. All right, call up your parents, folks, you know, I'm just kidding.

  150. It's like, I was blown away.